RTOG 89-03 Phase III trial • median follow-up: 60 months. • percent of the patients completed the protocol: 74% – 67% on arm 1 and 81% on arm 2 • actu
{"Image DocumentName": "RTOG Phase III trial median follow-up: 60 months.", "Image ImageDescription": "percent of the patients completed the protocol: 74% 67% on arm 1 and 81% on arm 2. actuarial 5-year overall survival rate was 49% 48% in arm 1 and 49% in arm 2. evidence of distant metastases at 5 years: 35% 33% in arm 1 and 39% in arm 2. 5-year survival rate with a functioning bladder: 38% 36% in arm 1 and 40% in arm 2. None of these differences are statistically significant. Shipley WU, et al. J Clin Oncol 1998;16(11):3576.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}